NCT02693535 2026-04-02
TAPUR
American Society of Clinical Oncology
Phase 2 Recruiting
Clinical Trials
4 trialsNCT01281917 2019-12-13
Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
University of Wisconsin, Madison
Phase 2 Completed
NCT01653067 2016-10-27
STORM
University Hospital Heidelberg
Phase 2 Unknown
NCT01170052 2011-03-16
Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
Charite University, Berlin, Germany
Phase 1/2 Withdrawn